Code
3E013012
Looptijd
01-10-2012 → 30-09-2018
Financiering
Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
Promotor
Onderzoeksdisciplines
-
Natural sciences
- Organic chemistry
-
Medical and health sciences
- Morphological sciences
- Oncology
- Morphological sciences
- Oncology
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences
- Morphological sciences
- Oncology
Trefwoorden
metastasering
kanker
geneesmiddelenonderzoek
Projectomschrijving
The formation of metastases is the main cause of cancer-related mortality (90%). Strikingly, no effective anti-metastatic therapy is available in the clinic yet. N-Cadherin (NCad) is a protein that is abnormally active in metastatic tumors and helps them spread. The current project aims at developing molecules which can block NCad in patients.